Company
United StatesPublic company, NYSE: MDTMedtronic Inc (NYSE: MDT), Tempe, AZ – FDA Inspections
Inspection records and compliance data for Medtronic Inc in Tempe, Arizona. 4 FDA inspections on record, last inspected July 14, 2016. Publicly traded as NYSE: MDT.
Company Profile
This profile covers Medtronic Inc based in Tempe, Arizona, United States.
FDA Inspection History
- FDA inspections
- 4
- OAI
- 0
- VAI
- 1
- NAI
- 3
- Form 483s
- 0
- Warning letters
- 0
First inspected July 10, 2009. Last inspected July 14, 2016.
Most cited issue areas
- Return to inventory--procedures1 inspection
FDA inspections (4)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| July 14, 2016 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 982761 |
| May 14, 2013 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 833131 |
| December 30, 2010 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 703615 |
| July 10, 2009 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 595880 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Medtronic Inc
Stock ticker
MDT
Exchange
NYSE
Share price
$105.03
Market cap
$134.3B
Price as of
November 6, 2026
FEI Number
3004185781
Address
2343 W Medtronic Way, Tempe, Arizona 85281, United States
Country
United States
ID: 199eeb17-5c9f-4927-baa6-0afe0904ce37